Transcat, Inc. (NASDAQ:TRNS) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Transcat, Inc. (NASDAQ:TRNSGet Free Report) have received a consensus recommendation of “Moderate Buy” from the five brokerages that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $130.25.

Several brokerages have recently issued reports on TRNS. Northland Securities decreased their target price on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a research report on Wednesday, October 30th. HC Wainwright restated a “buy” rating and set a $156.00 price objective on shares of Transcat in a report on Tuesday, October 29th. Oppenheimer reiterated an “outperform” rating and issued a $130.00 target price (down from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. Craig Hallum raised their price target on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, StockNews.com downgraded Transcat from a “hold” rating to a “sell” rating in a research note on Tuesday, October 29th.

Read Our Latest Research Report on TRNS

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Diversified Trust Co boosted its holdings in shares of Transcat by 53.6% in the fourth quarter. Diversified Trust Co now owns 6,120 shares of the scientific and technical instruments company’s stock worth $647,000 after acquiring an additional 2,135 shares during the period. Principal Financial Group Inc. boosted its stake in Transcat by 8.8% in the 3rd quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company’s stock worth $557,000 after purchasing an additional 373 shares during the period. Virtu Financial LLC grew its holdings in Transcat by 127.0% during the 3rd quarter. Virtu Financial LLC now owns 4,136 shares of the scientific and technical instruments company’s stock valued at $499,000 after buying an additional 2,314 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Transcat by 5.4% during the third quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock valued at $26,269,000 after buying an additional 11,106 shares during the period. Finally, Barclays PLC lifted its holdings in shares of Transcat by 393.0% in the third quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company’s stock worth $1,826,000 after buying an additional 12,061 shares in the last quarter. 98.34% of the stock is owned by institutional investors.

Transcat Stock Performance

Transcat stock opened at $105.98 on Friday. Transcat has a fifty-two week low of $94.29 and a fifty-two week high of $147.12. The firm’s 50-day simple moving average is $105.91 and its 200 day simple moving average is $117.02. The stock has a market cap of $974.91 million, a PE ratio of 53.53 and a beta of 0.71.

Transcat (NASDAQ:TRNSGet Free Report) last announced its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). The business had revenue of $67.83 million during the quarter, compared to analysts’ expectations of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. Transcat’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.41 EPS. As a group, analysts predict that Transcat will post 1.76 EPS for the current fiscal year.

About Transcat

(Get Free Report

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Further Reading

Analyst Recommendations for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.